Theliatinib (HMPL-309)

98%

  • Product Code: 63067
  CAS:    1353644-70-8
Molecular Weight: 444.23 g./mol Molecular Formula: C₂₅H₂₈N₆O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: Theliatinib (HMPL-309) is primarily used in the field of oncology as a targeted therapy for cancer treatment. It functions as an inhibitor of the epidermal growth factor receptor (EGFR), which is often overexpressed or mutated in various types of cancers, including non-small cell lung cancer (NSCLC). By blocking EGFR signaling, it helps to inhibit tumor growth and proliferation. This makes it a potential therapeutic option for patients with EGFR-driven cancers, particularly those who may have developed resistance to first-generation EGFR inhibitors. Clinical trials are ongoing to evaluate its efficacy, safety, and potential as part of combination therapies in cancer treatment regimens.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.010 10-20 days ฿46,431.00
+
-
Theliatinib (HMPL-309)
Theliatinib (HMPL-309) is primarily used in the field of oncology as a targeted therapy for cancer treatment. It functions as an inhibitor of the epidermal growth factor receptor (EGFR), which is often overexpressed or mutated in various types of cancers, including non-small cell lung cancer (NSCLC). By blocking EGFR signaling, it helps to inhibit tumor growth and proliferation. This makes it a potential therapeutic option for patients with EGFR-driven cancers, particularly those who may have developed resistance to first-generation EGFR inhibitors. Clinical trials are ongoing to evaluate its efficacy, safety, and potential as part of combination therapies in cancer treatment regimens.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :